Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
Condition: Coronary Artery Disease · Sponsor: Novartis Pharmaceuticals
About this study
CKJX839D12303 is a research study to determine if the study treatment, called inclisiran, in comparison to placebo taken in addition to statin medication can effectively reduce the total amount of plaque formed in the heart's vessels as measured by coronary computed tomography angiography (CCTA) from baseline to month 24. This study is being conducted in eligible participants with a diagnosis of non-obstructive coronary artery disease (NOCAD), where the coronary arteries are blocked less than 50%, and with no previous cardiovascular events.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (89)
| Heart Center Research Llc | Huntsville, Alabama, United States | — |
| Alaska Heart and Vascular | Anchorage, Alaska, United States | — |
| Cardiovascular Res Found | Beverly Hills, California, United States | — |
| UC San Diego Health | La Jolla, California, United States | — |
| Stanford Health Care | Stanford, California, United States | — |
| Lundquist Inst BioMed at Harbor | Torrance, California, United States | — |
| Bridgeport Hospital | Bridgeport, Connecticut, United States | — |
| George Washington Univ Medical Ctr | Washington D.C., District of Columbia, United States | — |
| Inpatient Research Clinical LLC | Miami Lakes, Florida, United States | — |
| NorthShore University Health System | Evanston, Illinois, United States | — |
| Reid Physician Associates | Richmond, Indiana, United States | — |
| Midwest Heart and Vascular Spec | Overland Park, Kansas, United States | — |
+ 77 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05360446